CRTX Cortexyme Inc

Price (delayed)

$63.22

Market cap

$1.87B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.8

Enterprise value

$1.79B

Highlights
The debt has soared by 200% YoY but it has decreased by 18% QoQ
The quick ratio has contracted by 34% YoY but it has grown by 4.6% from the previous quarter
The net income has shrunk by 71% YoY and by 8% QoQ
The EPS has declined by 47% year-on-year and by 6% since the previous quarter

Key stats

What are the main financial stats of CRTX
Market
Shares outstanding
29.59M
Market cap
$1.87B
Enterprise value
$1.79B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
11.94
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$82.76M
EBITDA
-$82.43M
Free cash flow
-$50.87M
Per share
EPS
-$2.8
Free cash flow per share
-$1.72
Book value per share
$5.3
Revenue per share
$0
TBVPS
$5.91
Balance sheet
Total assets
$174.52M
Total liabilities
$18.04M
Debt
$171,000
Equity
$156.48M
Working capital
$132.02M
Liquidity
Debt to equity
0
Current ratio
8.39
Quick ratio
8.23
Net debt/EBITDA
1.03
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-42%
Return on equity
-45.8%
Return on invested capital
-75.1%
Return on capital employed
-52.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CRTX stock price

How has the Cortexyme stock price performed over time
Intraday
10.83%
1 week
6%
1 month
14.63%
1 year
54.8%
YTD
127.57%
QTD
19.28%

Financial performance

How have Cortexyme's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$84.35M
Net income
-$82.76M
Gross margin
N/A
Net margin
N/A
The net income has shrunk by 71% YoY and by 8% QoQ
CRTX's operating income has dropped by 66% year-on-year and by 7% since the previous quarter

Growth

What is Cortexyme's growth rate over time

Valuation

What is Cortexyme stock price valuation
P/E
N/A
P/B
11.94
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 47% year-on-year and by 6% since the previous quarter
CRTX's P/B is 84% above its last 4 quarters average of 6.5
The equity has decreased by 28% YoY and by 9% QoQ

Efficiency

How efficient is Cortexyme business performance
The ROIC has declined by 44% year-on-year and by 23% since the previous quarter
The ROE has decreased by 41% YoY and by 17% QoQ
Cortexyme's ROA has decreased by 37% YoY and by 15% from the previous quarter

Dividends

What is CRTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CRTX.

Financial health

How did Cortexyme financials performed over time
CRTX's total liabilities is up by 37% YoY and by 4.8% from the previous quarter
The current ratio has contracted by 35% YoY but it has grown by 3.5% from the previous quarter
The debt is 100% lower than the equity
The debt has soared by 200% YoY but it has decreased by 18% QoQ
The equity has decreased by 28% YoY and by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.